APA (7th ed.) Citation

Han, T., Li, X., Xu, L., Sun, J., Hao, J., Shi, S., . . . Zhao, M. A real-world study on the efficacy and safety of low-dose PD-1 monoclonal antibody alone or in combination as the first-line treatment for advanced non-small cell lung cancer. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Han, Tao, Xin Li, Lu Xu, Jingqi Sun, Junli Hao, Sha Shi, Heming Li, and Mingfang Zhao. A Real-world Study on the Efficacy and Safety of Low-dose PD-1 Monoclonal Antibody Alone or in Combination as the First-line Treatment for Advanced Non-small Cell Lung Cancer. BMJ Publishing Group.

MLA (9th ed.) Citation

Han, Tao, et al. A Real-world Study on the Efficacy and Safety of Low-dose PD-1 Monoclonal Antibody Alone or in Combination as the First-line Treatment for Advanced Non-small Cell Lung Cancer. BMJ Publishing Group.